Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate - Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Navigation: NDC > Supplier starting with: G > GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.| Field | Value |
|---|---|
| NDC Code: | 0115-1332 |
| Proprietary Name: | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
| Suffix: | |
| Non-Proprietary Name: | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
| Dosage Form: | CAPSULE, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 30-09-2009 |
| Category Name: | NDA AUTHORIZED GENERIC |
| Application Number: | NDA021303 |
| Labeler: | GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC. |
| Substance Name: | AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
| Active Numerator Strength: | 6.25; 6.25; 6.25; 6.25 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule: | CII |